RadNet, Inc. (RDNT) Dividend History

RadNet, Inc. (RDNT) is a leading provider of outpatient diagnostic imaging services in the United States. Established in 1984, the company operates numerous imaging centers, offering services such as MRI, CT, ultrasound, and mammography. RadNet focuses on delivering high-quality, accessible, and cost-effective imaging care, serving hospitals, outpatient clinics, and physicians. It aims to enhance patient outcomes through advanced technology and integrated care solutions.

1510 Cotner Ave, Los Angeles, CA, 90025
Phone: (310) 478-7808
Website: http://www.radnet.com

Dividend History

RadNet, Inc. currently does not pay dividends

Company News

  • Healthcare AI Market Explodes 38.5% Annually as Diagnostics Gain FDA Traction

    The global AI in healthcare market is projected to reach nearly $700 billion by 2034, growing at 38.5% annually. Companies are developing advanced AI diagnostic technologies targeting areas like diabetic retinopathy, cardiac screening, and chronic disease management, with increasing FDA approvals and commercial potential.

    Benzinga
    Featured Companies: BFLY CLOV TVGN
  • RadNet Posts Record Q2 Revenue Up 8%

    RadNet reported record Q2 2025 revenue of $498.2 million, exceeding analyst expectations, driven by advanced imaging procedures and digital health solutions. The company raised full-year 2025 guidance and demonstrated strong operational performance.

    The Motley Fool
  • RadNet, Inc. Announces Date of its Second Quarter 2025 Financial Results Conference Call

    RadNet, a national diagnostic imaging services provider, will host a conference call on August 11, 2025, to discuss its second quarter 2025 financial results. The company owns 401 outpatient imaging centers across multiple states and provides radiology technology solutions.

    GlobeNewswire Inc.
  • RadNet (RDNT) Reports Q2 Earnings: What Key Metrics Have to Say

    RadNet reported revenue of $459.71 million, up 13.9% year-over-year, and EPS of $0.16 in Q2 2024. The company's performance was mixed compared to analyst estimates.

    Zacks Investment Research
Page data last updated 09/07/2025 04:30:41 UTC